SCHEMBL370595

SCHEMBL370595

COc1ccc(Cn2cc3c(n2)N(CC2CCN(C(=O)OC(C)(C)C)CC2)CCCC3=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.47
GPR119 Q8TDV5 6/20 0.45
KDM1A O60341 1/20 0.45
ALDH1A1 P00352 3/20 0.42
STS P08842 1/20 0.41
AADAT Q8N5Z0 1/20 0.41
PIK3CA P42336 1/20 0.41
PRKDC P78527 1/20 0.41
KDM4E B2RXH2 2/20 0.41
HPGD P15428 2/20 0.41
HTT P42858 2/20 0.41
CTSD P07339 1/20 0.41
CTSE P14091 1/20 0.41
MEN1 O00255 1/20 0.41
TSHR P16473 1/20 0.41
CRHBP P24387 1/20 0.41
KMT2A Q03164 1/20 0.41
CRHR2 Q13324 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TP53 P04637 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL369936 0.86 BACE1 (0.46) BACE1GPR119KDM1AALDH1A1STS
SCHEMBL367340 0.86 AADAT (0.44) BACE1AADAT
SCHEMBL370594 0.82 AADAT (0.39) ALDH1A1AADATKMT2A
SCHEMBL15129782 0.78 AADAT (0.45) ALDH1A1AADATMEN1KMT2A
SCHEMBL16242858 0.77 SMN1; SMN2 (0.44) ALDH1A1AADATKDM4EHTTMEN1
SCHEMBL370406 0.76 MERTK (0.38) BACE1GPR119KDM1AALDH1A1STS
SCHEMBL16242764 0.76 AADAT (0.45) ALDH1A1AADATMEN1KMT2AHSD17B10
SCHEMBL367029 0.76 SIGMAR1 (0.45) AADATKDM4EHTTMEN1KMT2A
SCHEMBL366278 0.76 AADAT (0.43) ALDH1A1AADATKDM4EHPGDMEN1
SCHEMBL366569 0.75 AADAT (0.43) ALDH1A1AADATKDM4EHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9765091-B2 Tetrahydropyrazolo [3,4-b] azepine derivatives and their use as allosteric modulators of metabotropic glutamate receptors ADDEX PHARMA S.A. (CH) 2017-09-19 US disclosed
EP-2592932-B1 NOVEL TETRAHYDROPYRAZOLO[3,4-B]AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA SA (CH) 2016-01-20 EP disclosed
US-20130267499-A1 NOVEL TETRAHYDROPYRAZOLO [3,4-b] AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA SA (CH) 2013-10-10 US disclosed
EP-2592932-A2 NOVEL TETRAHYDROPYRAZOLO[3,4-B]AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Addex Pharma SA (CH) 2013-05-22 EP disclosed
WO-2012009001-A2 NOVEL TETRAHYDROPYRAZOLO[3,4-B]AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA S.A. (CH) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130267499-A1 NOVEL TETRAHYDROPYRAZOLO [3,4-b] AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS GRM4, GRM1, GRIK4 BACE1 2270/4885GPR119 40/4885KDM1A 1265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.